ʻO ka lawe ʻana i ka home no ʻEulopa, US, Kanada, Australia!
E ʻoluʻolu: ʻAʻole ʻae ʻo AASraw i nā mea kūʻai aku.

ʻO kaʻaeʻole (GVS-111) ka paukū

Rating: SKU: 157115-85-0. Māhele:

Nā inoa'ē aʻe:GVS-111, Noopept

ʻO AASraw ka mea hanaʻoihana o Noopept raw powder nona ka lab kūʻokoʻa a me ka hale hana nui e like me ke kākoʻo, e hanaʻia nā hana a pau ma lalo o ke kānāwai CGMP a me ka'ōnaehana mālama maikaʻi. He kūpaʻa ka ʻōnaehana hoʻolako, ʻae ʻia nā kauoha kūʻai a me nā mea kūʻai nui. Welcome e kauoha mai AASraw!

ʻŌlelo wikiwiki no ke kauoha liʻiliʻi

Inā pono ʻoe e kūʻai i kēia huahana ma ka nui, e ʻoluʻolu e hoʻohana i ke kahawai VIP e kiʻi i ke kumukūʻai hoʻokūkū loa.????

Kauoha Nui

Product Description

1. Noopept Powder Video-AASraw

 


2. Noopept Paʻa Kūʻai Kumu

Name: Noopepili (GVS-111) ka paukū
CAS: 157115-85-0
Kaulike Molecular: C17H22N2O4
Kaumaha Molecular: 318.37
Wahi Manaʻo: 97-98 ° C
Hōʻoia Kōkua: Pūmole
kala like 'ole: ʻO kaʻeleʻeleʻo Crystallineʻeleʻele a iʻole keʻokeʻo

 


Heaha is Noopept Powder?

ʻO Noopept kahi mea hoʻonui hoʻonui cognitive kaulana i ke kaiāulu nootropic. ʻO nā hana i manaʻo ʻia e pili ana i nā haʻawina preclinical e pili ana i ka hoʻonui ʻana i ka hōʻailona acetylcholine, ka hoʻonui ʻana i ka hōʻike o BDNF a me NGF, ka pale ʻana mai ka glutamate toxicity, a me ka hoʻonui ʻana i ka neurotransmission inhibitory i ka lolo.

I loko o ke kaiāulu nootropic, Noopept he mea hoʻohui maikaʻi no ka hoʻomaikaʻi ʻana i ka hana cognitive. ʻO ka hoʻonui ʻana i ka hōʻailona cholinergic, hoʻonui i ka BDNF a me ka hōʻike NGF, ka pale ʻana i ka glutamate toxicity, a me ka hoʻonui ʻana i ka neurotransmission inhibitory i loko o ka lolo kekahi o nā hana i manaʻo ʻia e pili ana i ka noiʻi preclinical.

He aha ka maikaʻi o Noopept?

He kū hoʻokahi ʻo Noopept ma muli o kona mana a me ka wikiwiki o ka hana, a me ka helu o nā pono cognitive hiki iā ia ke hāʻawi.

ʻAʻole hiki iā ʻoe ke hoʻokō i nā pono olakino cognitive a me ka noʻonoʻo ma nā haʻahaʻa haʻahaʻa, akā ʻoi aku ka nui o ka anti-anxiety a me nā hopena neuroprotective me ka noopept ma mua o nā nootropics ʻē aʻe.

Inā hakakā ʻoe me ka noe o ka lolo, ka hopohopo, ke kaumaha, ka ʻeha o ka lolo, a i ʻole ka emi ʻana o ka cognitive pili i ka makahiki, ʻo ka noopept wale nō ka mea.

ka Nā pōmaikaʻi o Noopept

Hana lolo

ʻO ka hiʻohiʻona nui o Noopept ka mālama ʻana i ka pono o kou lolo. Hiki ke kapa ʻia kēia mea hoʻohui he cognitive enhancer e hoʻomaikaʻi i ka hoʻomanaʻo a me ka hana aʻo. ʻO ka mea maʻamau, ʻōlelo ka poʻe loea e lawe iā Noopept ma mua o nā hana noʻonoʻo noʻonoʻo ma muli o nā kumu he nui: ua haʻi mua mākou i ka mea mua, ʻo ia ka hopena hopena; ʻo ka lua ka hoʻoikaika hoʻomanaʻo; a ʻo ke kolu ka hoʻonui ʻana i ka nānā. No laila ʻo ka mea a Noopept e hana ai ʻaʻole wale ka hoʻonui ʻana i ka manaʻo, kōkua pū ia i ka hoʻohui ʻana i kou mana noʻonoʻo i ka wā e pono ai ʻoe.

Hiki i ka Noopept ke lawelawe ma ke ʻano he mea hana pale no ka emi ʻana o ka cognitive. ʻO ka poʻe i loaʻa ka moʻolelo ʻohana me ka lolo a i ʻole ke alo i kēia mau mea e hoʻāʻo e hoʻokomo iā Noopept i kā lākou hana maʻamau i kēlā me kēia lā (ʻoiaʻiʻo me nā ʻōlelo kuhikuhi i wehewehe ʻia). Eia naʻe, ʻaʻole hiki i ka nele o nā noiʻi hohonu e pili ana iā Noopept ke hōʻoia i kahi hopena ikaika.

Alzheimer ka maʻi

ʻOiai ua haʻi mākou i ka hiʻohiʻona koʻikoʻi e pili ana i ka emi ʻana o ka hoʻomanaʻo, pono e hoʻokaʻawale i ka hihia o Alzheimer. ʻO ia ke kumu o ka protein amyloid, ka mea e hoʻomaka pinepine ai i ka puka ʻana o Alzheimer. ʻO ka mea a Noopept e hana ai ʻo ia ka hōʻemi ʻana i nā pae amyloid, ʻo ia ka mea e hōʻemi i ka hiki ke alo iā Alzheimer ma hope o ke ola.

Hoemi i ka hopohopo

ʻO kekahi hiʻohiʻona o ka Noopept supplement ke kākoʻo o kou kūpaʻa noʻonoʻo a i ʻole, ka hoʻopau ʻana i nā manaʻo hopohopo. Hoʻopili ʻo Noopept me ka ʻāpana o ko mākou lolo i kapa ʻia ʻo Hippocampus a ma laila e hoʻoulu ai i ka ʻano anti-anxious. Ma ia ʻano, hoʻopiha ʻo Noopept iā mākou me ka maluhia a me ka hōʻoluʻolu.

Wahi a nā ʻike ʻepekema ʻē aʻe he hopena koʻikoʻi ka Noopept i ka poʻe me ka ʻeha cerebral a kōkua i ka mālama ʻana i nā ʻeha lolo. ʻO ia paha e pili ana i ka hiʻohiʻona mua - ka hoʻomaikaʻi ʻana i ka hana cognitive -, a ʻo ka lua - ka pilina me Hippocampus.

Pākuʻi

Loaʻa i ka Noopept nā hiʻohiʻona antioxidant e hiki ke lawelawe i ka hoʻemi ʻana o ka mumū a i ʻole ka pale ʻana i kekahi mau hihia o ka maʻi kanesa. E like me kā mākou e ʻike ai, hakakā nā antioxidants i nā radical manuahi a ma ia ʻano, kūkulu i kahi pale no nā cell e mālama iā lākou mai ka pōʻino. Hōʻike ʻia nā anti-inflammatory i ka noʻonoʻo a me ke kino mai kekahi ʻeha i manaʻo ʻole ʻia a hōʻoia i ke olakino holoʻokoʻa.

ʻAeʻole hoʻohana ʻia no ka hoʻomaikaʻi ʻana i ka hana cognitive

Hiki i ka Noopept ke kōkua no nā kumu like ʻole a hiki ke hoʻomaikaʻi i ka hana cognitive, hoʻomanaʻo, hana, a me ke olakino lolo.

Hele koke ia ma ka pale koko-lolo me ka haʻahaʻa haʻahaʻa, a ʻike pinepine ʻia ka hopena.

He palekana ka hoʻohana ʻana i ka noopept i ka wā e lawe ai ʻoe i nā kau i ʻōlelo ʻia. ʻOi aku ka maikaʻi e hoʻomaka liʻiliʻi, ʻaʻohe kumu o kou lawe ʻana.

Hāʻawi ʻo Noopept i nā mana anti-anxiety a me nā neuroprotective ma mua o nā nootropics ʻē aʻe, e like me ka piracetam, ka mea e hoʻonui ai i kona kaulana.

Kahi e kūʻai ʻAeʻole Pauda?

ʻO Noopept kahi mea hoʻonui hoʻonui cognitive potent. Hiki ke kōkua i ka hoʻonui ʻana i ka hoʻomanaʻo, ke ʻano kaulike, a me ka hoʻonui ʻana i ka wikiwiki o ka ulu ʻana o ka synaptic i ka lolo. Hoʻolālā mua ʻia e hana ma ke ʻano he mana ikaika o ka piracetam, noopept e noho nei kekahi o nā nootropics kaulana loa i loaʻa i kēia lā.

Hōʻike hōʻike hōʻike ʻo Raw Noopept Powder-HNMR

Noopept (GVS-111) pauka HNMR

He aha ka HNMR a He aha ka HNMR spectrum e haʻi aku iā ʻoe? ʻO H Nuclear Magnetic Resonance (NMR) spectroscopy kahi ʻenehana kemika analytical i hoʻohana ʻia i ka hoʻokele maikaʻi a me ka noiʻi no ka hoʻoholo ʻana i ka ʻike a me ka maʻemaʻe o kahi laʻana a me kona ʻano molekala. No ka laʻana, hiki i ka NMR ke hoʻokaʻawale i nā hui pū ʻia i ʻike ʻia. No nā pūhui i ʻike ʻole ʻia, hiki ke hoʻohana ʻia ka NMR e hoʻohālikelike i nā hale waihona puke spectral a i ʻole e kuhi pololei i ke ʻano kumu. Ke ʻike ʻia ke ʻano kumu, hiki ke hoʻohana ʻia ka NMR no ka hoʻoholo ʻana i ka conformation molecular i ka hopena a me ke aʻo ʻana i nā waiwai kino ma ka pae molekala e like me ka hoʻololi conformational, nā hoʻololi ʻana, ka solubility, a me ka diffusion.

Noopept(157115-85-0)-COA

Noopept(157115-85-0)-COA

Pehea e kūʻai ʻAeʻole Pauka mai AASraw?

❶E hoʻokaʻaʻike mai iā mākou ma kā mākou ʻōnaehana nīnau leka uila, a i ʻole e waiho i kāu helu whatsapp iā mākou, e hoʻopili kā mākou mea kūʻai aku (CSR) me ʻoe i loko o 12 mau hola.

❷E hāʻawi mai iā mākou i kāu helu a me kāu helu wahi i nīnau ʻia.

❸Na kā mākou CSR e hāʻawi iā ʻoe i ka ʻōlelo, ka manawa uku, ka helu ʻimi, nā ala hoʻouna a me ka lā i manaʻo ʻia (ETA).

❹E uku ʻia a hoʻouna ʻia nā waiwai i loko o 12 mau hola.

❺ Loaʻa nā waiwai a hāʻawi i nā manaʻo.

Mea kākau o kēia ʻatikala:
Kauka Monique Ua puka 'o Hong mai ke Kula Nui o UK Imperial College London Faculty of Medicine

Mea kākau moʻolelo puke moʻolelo ʻepekema:
1. Igor S. Povarov
ʻO ke Keʻena ʻEpekema Brain, Center Research of Neurology, 105064 Moscow, Russia
2. Halil Düzova
Ke Kulanuiʻo Inonu, Kumu o ka Lapaʻau, Keʻena o Physiology, Malatya, Turkey
3. Praveen K. Srivastava
Shri GH Patel Pharmacy Building, Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Fatehgunj, Vadodara 390 002, Gujarat, India
4. Xueen Jia
Keʻena ʻOihana Biochemistry a me Biophysics, Ke Kulanui ʻo Umeå, SE-90187 Umeå, Kuekene
ʻAʻole ʻae kēia kauka/ ʻepekema i ke kūʻai, kūʻai ʻana, a hoʻohana paha i kēia huahana no kekahi kumu. ʻAʻohe pili a pili ʻole ʻo Aasraw, i hōʻike ʻia a i ʻole, me kēia kauka. ʻO ke kumu o ka haʻi ʻana i kēia kauka, ʻo ia ka hoʻomaikaʻi, hoʻomaikaʻi a hoʻomaikaʻi i ka hana noiʻi a me ka hoʻomohala piha i hana ʻia e nā ʻepekema e hana nei i kēia mea.

Reference

[1] Suliman, NA, Mat Taib, CN, Mohd Moklas, MA, Adenan, MI, Hidayat Baharuldin, MT a me Basir, R. (2016). Hoʻokumu i nā Nootropics Natural: Hoʻonui Molecular Hoʻonui i hoʻopili ʻia e Natural Nootropic. ʻO ka lāʻau lapaʻau hoʻohui a me nā lāʻau lapaʻau ʻē aʻe, [online] 2016, pp.1–12.

[2] Picciotto, Marina R., Higley, Michael J. a me Mineur, Yann S. (2012). ʻO Acetylcholine ma ke ʻano he Neuromodulator: Hoʻohālikelike ʻo Cholinergic Signaling i ka hana a me ke ʻano o ka ʻōnaehana Nervous. Neuron, [online] 76(1), pp.116–129.

[3] Gudasheva, TA, Grigoriev, VV, Koliasnikova, KN, Zamoyski, VL a me Seredenin, SB (2016). ʻO Neuropeptide cycloprolylglycine kahi modulator maikaʻi endogenous o nā mea loaʻa AMPA. Doklady Biochemistry and Biophysics, [online] 471(1), pp.387–389.

[4] Tejeda, GS, Esteban‐Ortega, GM, San Antonio, E., Vidaurre, Ó.G. a me Díaz‐Guerra, M. (2019). ʻO ka pale ʻana i ka hana excitotoxicity-induced o BDNF receptor TrkB-FL alakaʻi i ka neuroprotection stroke. EMBO Molecular Medicine, [online] 11(7).

[5] Voronina TA;Guzevatykh LS;Trofimov SS (2021). [Ka hoʻohālikelike ʻana i nā hopena o ka noopept a me ka piracetam i nā ʻiole kāne makua a me nā ʻiole wahine i ka wā postnatal]. Eksperimental'naia i klinicheskaia farmakologiia, [online] 68(2).


E kiʻi i kahi hōʻaiʻē nui